Literature DB >> 185151

Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems.

B Forghani, N J Schmidt, E H Lennette.   

Abstract

Hamsters immunized with human cytomegalovirus (CMV) concentrated and purified by polyethylene glycol precipitation and density gradient centrifugation produced antisera with high titers of specific viral antibody, and which showed no significant reactivity with human host cell components. The antisera had high titers of CMV antibody in complement fixation, indirect fluorescent-antibody (FA), and neutralization tests, but titers obtained by indirect radioimmunoassay (RIA) were markedly higher. The antisera were used to follow the development of CMV antigen in infected host cells by indirect RIA and indirect FA staining. Virus-specific antigen was first detectable by RIA at 8 h after infection, and by FA staining at 16 h; cells contained optimal amounts of antigen for RIA and FA assays at 72 to 100 h postinfection. Immune globulins from the antisera were labeled with 125I for use in direct RIA. The labeled globulins gave highly specific reactions with CMV-infected cells, including those infected with low-passage isolates, and showed no reactivity with cells infected with other human herpesviruses or certain other human viruses.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185151      PMCID: PMC415512          DOI: 10.1128/iai.14.5.1184-1190.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  A simple fractionation method for preparation of fluorescein-labeled gamma globulin.

Authors:  J L RIGGS; P C LOH; W C EVELAND
Journal:  Proc Soc Exp Biol Med       Date:  1960-12

2.  Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus.

Authors:  N E Cremer; N J Schmidt; F Jensen; M Hoffman; L S Oshiro; E H Lennette
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

3.  Partial characterization of a soluble antigen preparation from cells infected with human cytomegalovirus: properties of antisera prepared to the antigen.

Authors:  J L Waner
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

4.  Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

5.  Nonviral microbodies with viral antigenicity produced in cytomegalovirus-infected cells.

Authors:  J E Craighead; R E Kanich; J D Almeida
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

6.  Preparation of specific antisera to cytomegaloviruses in goats.

Authors:  H G Haines; R Von Essen; M Benyesh-Melnick; J L Melnick
Journal:  Proc Soc Exp Biol Med       Date:  1971-12

7.  Immunofluorescent staining in the laboratory diagnosis of varicella-zoster virus infections.

Authors:  N J Schmidt; E H Lennette; J D Woodie; H H Ho
Journal:  J Lab Clin Med       Date:  1965-09

8.  Demonstration of immunoglobulin G receptors induced by human cytomegalovirus.

Authors:  T Furukawa; E Hornberger; S Sakuma; S A Plotkin
Journal:  J Clin Microbiol       Date:  1975-10       Impact factor: 5.948

9.  An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts.

Authors:  R Keller; R Peitchel; J N Goldman; M Goldman
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

10.  Solid phase radioimmunoassay for typing herpes simplex viral antibodies in human sera.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  J Clin Microbiol       Date:  1975-11       Impact factor: 5.948

View more
  14 in total

1.  Possible pitfalls in the study of IgG receptors produced by herpesvirus-infected cells. Brief report.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Comparison of enzyme-linked immunosorbent assay (ELISA) technique and complement-fixation test for estimation of cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T A Aziz; H Stern
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

3.  Comparison of biotinylated DNA and RNA probes for rapid detection of varicella-zoster virus genome by in situ hybridization.

Authors:  B Forghani; G J Yu; J W Hurst
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

4.  Anti-complement immunofluorescence test for antibodies to human cytomegalovirus.

Authors:  J D Kettering; N J Schmidt; D Gallo; E H Lennette
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

5.  Analysis of antigenic diversity among human cytomegaloviruses by kinetic neutralization tests with high-titered rabbit antisera.

Authors:  J L Waner; T H Weller
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

6.  Serological reactivity of some monoclonal antibodies to varicella-zoster virus.

Authors:  B Forghani; N J Schmidt; C K Myoraku; D Gallo
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Visual reading of enzyme immunofluorescence assays for human cytomegalovirus antibodies.

Authors:  B Forghani; J Dennis; N J Schmidt
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948

8.  Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T M Bakir; H Stern; H Kangro; P D Griffiths; R B Heath
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

9.  Solid-phase enzyme immunoassay for determination of antibodies to cytomegalovirus.

Authors:  R V Krishna; O H Meurman; T Ziegler; U H Krech
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

10.  Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera.

Authors:  L Pereira; M Hoffman; N Cremer
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.